Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

207.77
-0.2600-0.12%
Post-market: 207.770.00000.00%19:30 EDT
Volume:734.95K
Turnover:153.13M
Market Cap:10.88B
PE:-55.13
High:210.87
Open:207.22
Low:206.50
Close:208.03
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:1.37
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:130.64
PE(LYR):-56.43

Loading ...

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting

GlobeNewswire
·
May 26

Axsome Therapeutics (AXSM) Is Up 5.7% After AUVELITY Alzheimer’s Agitation Approval And Launch Push - Has The Bull Case Changed?

Simply Wall St.
·
May 14

Analysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Axsome Therapeutics (AXSM)

TIPRANKS
·
May 11

Axsome Therapeutics Recognizes Mental Health Month

GlobeNewswire
·
May 07

Axsome Therapeutics (AXSM) Q1 Loss Widening To US$64.5 Million Tests Profitability Narratives

Simply Wall St.
·
May 06

Axsome COO Mark Jacobson disposes of common shares worth $1.08 million

Reuters
·
May 06

B. Riley Adjusts Price Target on Axsome Therapeutics to $300 From $230, Maintains Buy Rating

MT Newswires Live
·
May 05

Axsome Therapeutics Inc : B. Riley Raises Target Price to $300.00 From $230.00

THOMSON REUTERS
·
May 05

Axsome Therapeutics Is Maintained at Outperform by Baird

Dow Jones
·
May 05

Axsome Therapeutics to present at BofA Securities Health Care Conference

Reuters
·
May 05

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and Merck & Company (MRK)

TIPRANKS
·
May 05

Mizuho Securities Keeps Their Buy Rating on Axsome Therapeutics (AXSM)

TIPRANKS
·
May 05

Morgan Stanley Sticks to Its Hold Rating for Axsome Therapeutics (AXSM)

TIPRANKS
·
May 05

U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi

Reuters
·
May 05

Axsome Therapeutics Inc : TD Cowen Raises Target Price to $275 From $255

THOMSON REUTERS
·
May 05

Axsome Therapeutics Earnings Call Signals Aggressive Growth

TIPRANKS
·
May 05

Axsome Therapeutics management to meet with Piper Sandler

TIPRANKS
·
May 05

Axsome Therapeutics Shares Rise 10.7% After Higher Q1 Revenue

THOMSON REUTERS
·
May 05

Axsome Therapeutics price target raised to $272 from $234 at Cantor Fitzgerald

TIPRANKS
·
May 05

Axsome Therapeutics Inc : Jefferies Raises Target Price to $275 From $245

THOMSON REUTERS
·
May 04